Citadel Advisors’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
69,272
-114,334
| -62% | -$296K | ﹤0.01% | 5044 |
|
|
2025
Q1 | $1.24M | Buy |
183,606
+82,153
| +81% | +$553K | ﹤0.01% | 3057 |
|
|
2024
Q4 | $689K | Buy |
101,453
+99,154
| +4,313% | +$673K | ﹤0.01% | 3666 |
|
|
2024
Q3 | $19.1K | Sell |
2,299
-147,911
| -98% | -$1.23M | ﹤0.01% | 5348 |
|
|
2024
Q2 | $952K | Buy |
150,210
+16,947
| +13% | +$107K | ﹤0.01% | 3088 |
|
|
2024
Q1 | $1.24M | Buy |
133,263
+78,332
| +143% | +$726K | ﹤0.01% | 2969 |
|
|
2023
Q4 | $700K | Buy |
54,931
+51,377
| +1,446% | +$655K | ﹤0.01% | 3382 |
|
|
2023
Q3 | $36.7K | Sell |
3,554
-6,452
| -64% | -$66.6K | ﹤0.01% | 5178 |
|
|
2023
Q2 | $131K | Sell |
10,006
-153,623
| -94% | -$2.01M | ﹤0.01% | 4629 |
|
|
2023
Q1 | $1.83M | Buy |
163,629
+92,810
| +131% | +$1.04M | ﹤0.01% | 2618 |
|
|
2022
Q4 | $597K | Sell |
70,819
-71,459
| -50% | -$602K | ﹤0.01% | 3692 |
|
|
2022
Q3 | $2.37M | Sell |
142,278
-121,193
| -46% | -$2.02M | ﹤0.01% | 2570 |
|
|
2022
Q2 | $3.88M | Buy |
263,471
+85,518
| +48% | +$1.26M | ﹤0.01% | 2103 |
|
|
2022
Q1 | $4.42M | Buy |
177,953
+82,432
| +86% | +$2.05M | ﹤0.01% | 2195 |
|
|
2021
Q4 | $3.06M | Sell |
95,521
-350,290
| -79% | -$11.2M | ﹤0.01% | 2592 |
|
|
2021
Q3 | $16M | Buy |
445,811
+178,267
| +67% | +$6.41M | ﹤0.01% | 1065 |
|
|
2021
Q2 | $11.8M | Buy |
267,544
+89,558
| +50% | +$3.95M | ﹤0.01% | 1314 |
|
|
2021
Q1 | $8.14M | Buy |
177,986
+48,241
| +37% | +$2.21M | ﹤0.01% | 1607 |
|
|
2020
Q4 | $8.96M | Buy |
+129,745
| New | +$8.96M | ﹤0.01% | 1337 |
|